Ariose Capital Management LTD I Mab Transaction History
Ariose Capital Management LTD
- $240 Million
- Q3 2025
A detailed history of Ariose Capital Management LTD transactions in I Mab stock. As of the latest transaction made, Ariose Capital Management LTD holds 1,704,393 shares of IMAB stock, worth $7.89 Million. This represents 2.68% of its overall portfolio holdings.
Number of Shares
1,704,393
Previous 96,455
1667.03%
Holding current value
$7.89 Million
Previous $233,000
2664.81%
% of portfolio
2.68%
Previous 0.15%
Shares
2 transactions
Others Institutions Holding IMAB
# of Institutions
40Shares Held
15.4MCall Options Held
10.2KPut Options Held
0-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$27.7 Million0.6% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC4.17MShares$19.3 Million3.04% of portfolio
-
Candriam S.C.A.1.13MShares$5.24 Million0.02% of portfolio
-
Sg Americas Securities, LLC464KShares$2.15 Million0.01% of portfolio
-
International Biotechnology Trust PLC London, X0310KShares$1.44 Million0.14% of portfolio
About I-Mab
- Ticker IMAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,098,800
- Market Cap $385M
- Description
- I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...